SkinHealth Systems Inc.
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and…
1D
-16.2%
1W
-4.0%
1M
-21.8%
6M
-42.1%
YTD
-62.0%
1Y
-63.3%
2Y
-67.6%
5Y
-97.9%
10Y
–
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~175% stronger price swings than usual
Pattern detected by the Market Jury detector vgolden-cross-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Golden Cross
BullishThe 50-day moving average crossed above the 200-day moving average. This is one of the best-known long-term trend-following signals in technical analysis.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
PRICE TARGET LOW
US$1.00
CONSENSUS
US$4.33
MEDIAN
US$2.00
PRICE TARGET HIGH
US$10.00
0
STRONG BUY
4
BUY
7
HOLD
3
SELL
0
STRONG SELL
14
TOTAL · Hold
As of: 12/08/2026
P/E
-2.34
P/B
1.23
EV/EBITDA
8.83
RETURN ON EQUITY
-4.8%
NET MARGIN
-3.7%
DEBT/EQUITY
6.6
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
61.5%
FLOAT SHARES
3,999,680
AVG. DAILY VOLUME (30D)
263,509
Malha Pedro Bruno Ferreira
Malha Pedro Bruno Ferreira
MONAHAN MICHAEL P.
SkinHealth Systems Inc. is a company in the Healthcare sector, Medical - Specialties industry, headquartered in United States.
The CEO is Pedro Malha, the company employs around 613 people.
The IPO was on 24/11/2020; the stock trades on NASDAQ under the ticker SKIN.
14 analysts rate the stock, the consensus is Hold (as of 12/08/2026).
The average price target is US$4.33, ranging from US$1.00 to US$10.00, with a median of US$2.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 175% stronger than usual.
No, SkinHealth Systems currently does not pay a dividend.
Comparable stocks include STERIS, QuidelOrtho, Mesa Laboratories, 908 Devices, Trinity Biotech, Eli Lilly and Company, Johnson & Johnson and AbbVie.
Clicking "Analyze stock" lets five strategies assess SkinHealth Systems against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.